Deliver Your News to the World

CybeRelease: (OTC: IDWD) Informed HLS to Proceed with $2.35 Tender Offer for IDS Common Shares


(CybeRelease, November 21, 2006) - Lake Harmony, PA - IDS Worldwide, Inc. (OTC PK: IDWD) HLS has informed IDS that it will proceed with the tender offer of $2.35 per share for the outstanding shares of IDS common stock following the completion of the spin-off of IDS division. IDS division is a separate asset that is not part of the HLS $2.35 cash buyout of IDS common shares. HLS also informed IDS that it expects the previously issued special dividend to begin trading after fiscal year end December 31, 2006.

IDS yesterday announced the record date for shareholders to qualify for the shares pertaining to the spin-off for November 30, 2006. To qualify shareholders must already own the shares or purchase the shares three trading days prior to November 30, 2006 to allow for the settlement of the trade (shareholders should note that November 23, 2006 will not count as a settlement day). IDS will determine through information provided by the company transfer agent to compile a list of shareholders who qualify for the spin-off as of the aforementioned record date.

To read the complete release, go to

Trident Microsystems, Inc. (Nasdaq: TRID), Check Point Software Technologies Ltd. (Nasdaq: CHKP), Cardica, Inc. (Nasdaq: CRDC),, Inc. (Nasdaq: BIDU), aQuantive, Inc. (Nasdaq: AQNT), NeuroMetrix, Inc. (Nasdaq: NURO), Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) and Wet Seal, Inc. (The) (Nasdaq: WTSLA).

CybeRelease Decliners are Crocs, Inc. (Nasdaq: CROX), Infosys Technologies Limited (Nasdaq: INFY), Cephalon, Inc. (Nasdaq: CEPH), ADTRAN, Inc. (Nasdaq: ADTN), Immucor, Inc. (Nasdaq: BLUD), Mesa Air Group, Inc. (Nasdaq: MESA), Orchid Cellmark Inc. (Nasdaq: ORCH) and Genesis HealthCare Corporation (Nasdaq: GHCI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. The company has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.